=
=
(400.162 MHz; CDCl3) 1.47 (6H, s, CH3), 1.50 (6H, s, CH3),
1.61 (1H, br, NH), 3.92 (3H, s, OCH3), 7.11 (1H, d, J 16.1 Hz,
(ATR) 2973 (alkyl CH), 1708 (C O), 1602 (C C), 1484 and
1403 (aryl C–C), 1373 and 1359 (NO) cm−1; EI MS found M+
510.22812 (0.14 ppm from calc. mass of C32H32NO5); m/z 510
(M+, 15%), 495 (9), 480 (100), 465 (10), 330 (40).
=
CH), 7.12 (1H, d, J 7.8 Hz, 7-H), 7.25 (1H, d, J 16.1 Hz,
CH), 7.28 (1H, d, J 1.2 Hz, 4-H), 7.42 (1H, dd, J 1.2 Hz
=
and 7.8 Hz, 6-H), 7.57 (2H, d, J 8.3 Hz, ArH), 8.02 (2H, d, J
8.3 Hz, ArH); dC (75.430 MHz; CDCl3) 31.8 (CH3), 31.9 (CH3),
5-[2-(4-Methylcarboxyphenyl)ethenyl]-2-methoxy-1,1,3,3-
tetramethylisoindoline (18)
=
=
52.0 (OCH3), 62.7 (C-1 and C-3), 119.6 ( CH), 121.8 ( CH),
126.2 (C-6), 126.3 (C-4), 127.0 (C-7), 128.8 (ArC), 130.0 (ArC),
131.3 (ArC), 136.1 (C-5), 142.0 (ArC), 149.3 (C-7a), 149.5
To a solution of the carboxystyryl substituted nitroxide 13
(40 mg, 0.114 mmol) and FeSO4·7H2O (64 mg, 0.230 mmol)
in DMSO (4 cm3) was added H2O2 (30%, 26 lL) dropwise and
the mixture was stirred at room temperature for 30 minutes.
The resultant solution was poured onto NaOH (1 M, 30 cm3)
and subsequently extracted with Et2O (3 × 50 cm3) and dried
(Na2SO4). Removal of solvent under reduced pressure gave the
carboxystyryl substituted N-methoxyisoindoline 18 (36.8 mg,
0.101 mmol, 89%). Recrystallisation from EtOH gave colourless
crystals of 18 (32.2 mg, 0.088 mmol, 77%); dH (400.162 MHz;
CDCl3) 1.45 (12H, br s, CH3), 1.61 (1H, br, NH), 3.80 (3H, s,
NOCH3), 3.92 (3H, s, ester OCH3), 7.10 (1H, d, J 16.2 Hz,
=
(C-3a), 166.9 (C O); mmax (ATR) 3351 (NH), 2962 (alkyl CH3),
=
=
1719 (C O), 1604 (C C), 1477 and 1435 (aryl C–C), 1178
(OCH3) cm−1; EI MS found (M–H)+ 334.18164 (2.81 ppm from
calc. mass of C22H24NO2 (M–H)); m/z 334 ((M–H)+, 14%), 320
(100), 305 (23), 304 (18), 144 (10).
5,6-Bis-[2-(4-methylcarboxyphenyl)ethenyl]-1,1,3,3-
tetramethylisoindoline (11)
5,6-Dibromo-1,1,3,3-tetramethylisoindoline (5) (300 mg,
0.90 mmol), K2CO3 (378 mg, 2.73 mmol), Pd(OAc)2 (12 mg,
0.054 mmol), PPh3 (24 mg, 0.092 mmol) and methyl 4-
vinylbenzoate (3) (360 mg, 2.21 mmol) were treated as described
above and heated in anhydrous DMF (15 cm3) for 142 hours at
100 ◦C. Column chromatography (70% EtOAc, 30% n-hexane;
then 80% EtOAc, 20% EtOH) and recrystallisation by mixed
solvent layer recrystallisation from DCM–n-pentane gave
off-white crystals of the disubstituted carboxystyryl isoindoline
amine 11 (50 mg, 0.101 mmol, 11%) mp 176–178 ◦C; dH
(400.162 MHz; CDCl3) 1.53 (12H, s, CH3), 1.74 (1H, br, NH),
=
CH), 7.11 (1H, d, J 8.1 Hz, 7-H), 7.23 (1H, d, J 16.2 Hz,
CH), 7.27 (1H, d, J 1.3 Hz, 4-H), 7.40 (1H, dd, J 1.3 Hz
=
and 8.1 Hz, 6-H), 7.56 (2H, d, J 8.3 Hz, ArH), 8.02 (2H, d,
J 8.3 Hz, ArH); dC (75.430 MHz; CDCl3) 25.2 and 29.1 (CH3
groups, broadened through ring inversion), 52.5 (ester OCH3),
65.9 (NOCH3), 67.8 (C-1 and C-3, broadened through ring
inversion), 120.0 ( CH), 122.3 ( CH), 126.7 (C-6), 126.8 (C-4),
127.5 (C-7), 129.2 (ArC), 130.4 (ArC), 131.7 (ArC), 136.6 (C-5),
=
=
=
142.3 (ArC), 146.2 (C-7a and C-3a), 167.3 (C O); mmax (ATR)
=
3.93 (6H, s, OCH3), 7.04 (2H, d, J 15.8 Hz, C–H), 7.34 (2H, s,
4-H and 7-H), 7.57 (2H, d, J 15.8 Hz, C–H), 7.59 (4H, d, J
=
=
2978 (alkyl CH3), 1714 (C O), 1603 (C C), 1493 and 1435 (aryl
C–C), 1178 (OCH3) cm−1; EI MS found M+ 365.19948 (1.05 ppm
from calc. mass of C23H27NO3); m/z 365 (M+, 5%), 350 (100),
319 (26), 304 (23).
=
8.2 Hz, ArH), 8.04 (4H, d, J 8.2 Hz, ArH); dC (75.430 MHz;
CDCl3) 31.7 (CH3), 52.1 (OCH3), 62.9 (C-1 and C-3), 119.8
=
=
( CH), 119.9 ( CH), 126.4 (C-4 and C-7), 129.1 (ArC), 130.1
(ArC), 130.3 (ArC), 135.4 (C-5 and C-6), 141.8 (ArC), 149.3
Fluorescence measurements
=
(C-3a and C-7a), 166.8 (C O); mmax (ATR) 3345 (NH), 3018
5-[2-(4-Methylcarboxyphenyl)ethenyl]-1,1,3,3-tetramethyliso-
indolin-2-yloxyl (13). The carboxystyryl nitroxide 13 (0.4 mg)
was dissolved in HPLC grade MeOH (100 cm3) in a volumetric
flask. The resulting solution (4.0 mg dm−3, 1.14 × 10−5 M)
was deoxygenated by bubbling with argon for 15 min. Any
subsequent solvent loss was replaced to maintain a known
concentration. Reduction of the carboxystyryl nitroxide 13 to
the hydroxylamine 16 was achieved by addition of a saturated
solution of ascorbic acid in HPLC grade MeOH (50 lL) to a
solution of 13 in MeOH (3 cm3) with stirring.
=
=
(aryl CH), 2955 (alkyl CH), 1708 (C O), 1603 (C C), 1479
and 1433 (aryl C–C), 1178 (OCH3) cm−1; EI MS found (M–H)+
494.23332 (0.38 ppm from calc. mass of C32H32NO4 (M–H)):
m/z 494 ((M–H)+, ∼1%), 480 (100), 465 (8), 320 (24).
5-[2-(4-Methylcarboxyphenyl)ethenyl]-1,1,3,3-
tetramethylisoindolin-2-yloxyl (13)
5-Bromo-1,1,3,3-tetramethylisoindolin-2-yloxyl (6) (100 mg,
0.38 mmol), K2CO3 (100 mg, 0.72 mmol), Pd(OAc)2 (4 mg,
0.018 mmol), PPh3 (8 mg, 0.031 mmol) and methyl 4-vinyl
benzoate (3) (80 mg, 0.491 mmol) were treated as above
and heated in anhydrous DMF (5 cm3) for 72 hours at
120 ◦C. Column chromatography (70% EtOAc, 30% n-hexane)
and recrystallisation from EtOH gave light orange needles
of the monosubstituted carboxystyryl isoindoline nitroxide 13
(113 mg, 0.323 mmol, 85%) mp 164–165 ◦C (found: C, 75.2; H,
6.9; N, 3.9. C22H24NO3 requires C, 75.4; H, 6.9; N, 4.0%); mmax
5,6-Bis-[2-(4-methylcarboxyphenyl)ethenyl]-1,1,3,3-tetrameth-
ylisoindolin-2-yloxyl (15). In a similar procedure to the one
described above, disubstituted carboxystyryl nitroxide 15
(0.4 mg) was dissolved in HPLC grade MeOH (100 cm3) in
a volumetric flask. This solution was further diluted by a
factor of 5. The resulting solution of 15 in MeOH (0.8 mg
dm−3, 1.57 × 10−6 M) was deoxygenated by bubbling with
argon for 15 min. Any subsequent solvent loss was replaced to
maintain the concentration. Similar to above, the reduction of
disubstituted carboxystyryl nitroxide 15 to the hydroxylamine
17 was achieved by addition of a saturated solution of ascorbic
acid in HPLC grade MeOH (50 lL) to the solution of 15 in
MeOH (3 cm3) with stirring.
=
=
(ATR) 2976 (alkyl CH), 1715 (C O), 1604 (C C), 1492 and
1434 (aryl C–C), 1373 and 1358 (NO), 1177 (OCH3) cm−1; EI MS
found M+ 350.17546 (0.46 ppm from calc. mass of C22H24NO3);
m/z 350 (M+, 30%), 335 (25), 320(100), 305 (42).
5,6-Bis-[2-(4-methylcarboxyphenyl)ethenyl]-1,1,3,3-
tetramethylisoindolin-2-yloxyl (15)
Acknowledgements
5,6-Dibromo-1,1,3,3-tetramethylisoindolin-2-yloxyl
(7)
(100 mg, 0.28 mmol), K2CO3 (154 mg, 1.11 mmol), Pd(OAc)2
(8 mg, 0.036 mmol), PPh3 (16 mg, 0.062 mmol) and methyl
4-vinylbenzoate (3) (120 mg, 0.737 mmol) were◦treated as above
and heated in anhydrous DMF (5 cm3) at 120 C for 72 hours.
Column chromatography (30% EtOAc, 70% n-hexane) and
subsequent recrystallisation from MeCN gave fine light yellow
needles of the disubstituted carboxystyryl isoindoline nitroxide
15 (78 mg, 0.152 mmol, 54%) mp 212–214 ◦C (decomp.); mmax
The authors acknowledge the financial support of the Australian
Research Council (DP0211669) and the National Cancer Insti-
tute (PO1 CA91597).
References
1 P. G. Griffiths, G. Moad, E. Rizzardo and D. H. Solomon,
Aust. J. Chem., 1983, 36, 397–401.
O r g . B i o m o l . C h e m . , 2 0 0 5 , 3 , 2 5 9 3 – 2 5 9 8
2 5 9 7